University of Warwick spin-out
Number of women in England receiving HRT on the NHS more than doubles
A record two million women were prescribed hormone replacement therapy in 2025/26 compared to 0.8 million in 2020/21
Medherant announces positive phase 1 results for testosterone patch for women
University of Warwick spin-out develops first-in-class testosterone patch to support women through menopause
Innovation in Action at AAFP FMX 2025
This year, Medscape Education is redefining the live learning experience at AAFP FMX 2025. With 8 groundbreaking, accredited symposia, we are proud to be at the heart of the meeting,...
Advertising For Women’s Health: Breaking Taboos and Driving Change
Our strategist Stephanie Goley, MSc, PhD takes a fascinating look at how advertising is breaking down stigmas around areas of women's health such as menstruation and menopause - and helping...
Bayer UK launches digital educational hub to improve menopause support
An estimated 13 million women in the UK are currently perimenopausal or menopausal
Bayer’s non-hormonal menopause drug shows promise in phase 3 breast cancer trial
Breast cancer patients can experience vasomotor symptoms as a result of adjuvant endocrine therapy
Bayer’s non-hormonal menopause drug elinzanetant shows promise in long-term study
Vasomotor symptoms are reported by up to 80% of women during the menopausal transition
Bayer’s non-hormonal menopause drug elinzanetant shows promise in phase 3 studies
Vasomotor symptoms are estimated to affect up to 80% of menopausal women
Astellas’ menopause drug granted EC approval to treat vasomotor symptoms
More than half of women aged 40 to 64 years experience symptoms such as hot flashes
Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
Vasomotor symptoms affect up to 80% of menopausal women in the US
New campaign to help guide conversations around the menopause at work for those working in health communications
This World Menopause Day, fox&cat, the Healthcare Communications Association (HCA) and The Menopause Charity have launched a joint campaign to help guide important conversations around the menopause at work for...
Astellas Pharma’s non-hormonal menopause drug granted FDA approval
Vasomotor symptoms affect up to 80% of menopausal individuals in the US